These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9398101)

  • 1. Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy.
    Sindone AP; Keogh AM; Macdonald PS; McCosker CJ; Kaan AF
    Am Heart J; 1997 Nov; 134(5 Pt 1):889-900. PubMed ID: 9398101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home inotropic therapy in children.
    Berg AM; Snell L; Mahle WT
    J Heart Lung Transplant; 2007 May; 26(5):453-7. PubMed ID: 17449413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient parenteral inotropic therapy for advanced heart failure.
    Young JB; Moen EK
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation.
    Apostolopoulou SC; Vagenakis GA; Tsoutsinos A; Kakava F; Rammos S
    Pediatr Cardiol; 2018 Oct; 39(7):1315-1322. PubMed ID: 29777282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
    Pacher R; Stanek B; Hülsmann M; Berger R; Siegel A; Daneschvar H; Rödler S; Frey B; Grimm M; Laufer G
    Eur Heart J; 1997 Feb; 18(2):318-29. PubMed ID: 9043849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure.
    Marius-Nunez AL; Heaney L; Fernandez RN; Clark WA; Ranganini A; Silber E; Denes P
    Am Heart J; 1996 Oct; 132(4):805-8. PubMed ID: 8831370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients.
    Applefeld MM; Newman KA; Sutton FJ; Reed WP; Roffman DS; Talesnick BS; Grove WR
    Am Heart J; 1987 Sep; 114(3):589-95. PubMed ID: 3630900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure.
    Upadya S; Lee FA; Saldarriaga C; Verma S; Sedrakyan A; Nystrom K; Katz SD
    J Heart Lung Transplant; 2004 Apr; 23(4):466-72. PubMed ID: 15063407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive inotropic drug infusions for patients with heart failure: current controversies and best practice.
    Gorski LA
    Home Healthc Nurse; 2002 Apr; 20(4):244-53; quiz 253-4. PubMed ID: 11984193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
    López-Candales AL; Carron C; Schwartz J
    Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenteral inotropic support for advanced congestive heart failure.
    Leier CV; Binkley PF
    Prog Cardiovasc Dis; 1998; 41(3):207-24. PubMed ID: 9872607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
    Cripe LH; Barber BJ; Spicer RL; Wong BL; Weidner N; Benson DW; Markham LW
    Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of intermittent inotropic therapy in unhospitalized patients with refractory heart failure.
    Moga VD; Luca C; Luca CT; Branea H; Drăgulescu SI
    Rom J Intern Med; 1999; 37(1):25-9. PubMed ID: 15523942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailored therapy using dobutamine and nitroglycerin in advanced heart failure.
    Drazner MH; Solomon MA; Thompson B; Yancy CW
    Am J Cardiol; 1999 Oct; 84(8):941-3, A7. PubMed ID: 10532519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient dobutamine for end-stage congestive heart failure.
    Miller LW; Merkle EJ; Herrmann V
    Crit Care Med; 1990 Jan; 18(1 Pt 2):S30-3. PubMed ID: 2293976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure].
    Brügemann J; de Jonge-Weber AT; Rienstra M; van den Broek SA; Zijlstra F; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2460-5. PubMed ID: 18064867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients.
    Frey B; Pacher R; Locker G; Bojic A; Hartter E; Woloszczuk W; Stanek B
    Chest; 2000 Jun; 117(6):1713-9. PubMed ID: 10858407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure.
    Nishi K; Sato Y; Miyamoto T; Toma M; Taniguchi R; Fukuhara R; Saijo S; Fujiwara H; Takatsu Y
    J Cardiol; 2012 May; 59(3):366-73. PubMed ID: 22365946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.